Dysphagia Knowledge Hub — 吞嚥困難知識庫

ALS/MND and Eating: Anticipatory Planning, PEG Timing, and Palliative Decisions in Hong Kong

Amyotrophic lateral sclerosis (ALS) — motor neurone disease (MND) in Commonwealth terminology — destroys the motor neurons controlling every voluntary movement including swallowing. Unlike most causes of dysphagia where rehabilitation can improve function, ALS follows an irreversible trajectory. Eating management in ALS is therefore not about recovery — it is about maintaining quality of life, preventing unnecessary complications, and making proactive decisions before each window of opportunity closes.

This article focuses on the anticipatory planning aspects of ALS eating management that are most likely to be encountered by patients, families, and non-specialist carers.

Recognising Early Bulbar Involvement

Approximately 25–30% of ALS patients present with bulbar-onset disease — their first symptoms are speech changes (dysarthria) and swallowing difficulties (dysphagia) rather than limb weakness. For limb-onset patients (70–75%), bulbar involvement typically emerges as the disease progresses over months to years.

The earliest swallowing signs are often subtle and may be dismissed as minor by both patients and clinicians:

Any of these signs in a person with known ALS should prompt referral to the speech-language therapist (SLT) — ideally at the next multidisciplinary clinic visit rather than waiting for a crisis.

IDDSI Progression: Staying Ahead of the Decline

The fundamental principle in ALS IDDSI management is anticipatory progression — moving to the next texture level before the current level becomes unsafe, not in response to an aspiration event.

A practical timeline framework

The rate of IDDSI progression varies widely across patients, but the direction is one-way. A useful approach is for the SLT to assess swallowing at every clinic visit and to specify the IDDSI level at which transition should happen, rather than waiting for the patient or family to report difficulty.

Stage 1 (early — IDDSI Level 7/6): Focus on reducing fatigue-inducing textures. Avoid tough meats, hard raw vegetables, mixed-texture foods (soup with chunks). Ensure adequate caloric density in modified foods — energy intake must remain high because ALS itself increases metabolic demand through fasciculations and compensatory effort. Dietitian input from this stage is essential.

Stage 2 (mid — IDDSI Level 5/4): Minced and moist or puréed foods. Thickening of liquids may begin — typically at IDDSI Level 1 (slightly thick) initially. Meal duration must be monitored and portions reduced if meals are taking >30 minutes. Supplement with high-calorie oral nutritional supplements (ONS) between meals.

Stage 3 (late oral — IDDSI Level 3/thickened liquids): Liquidised foods with moderately thickened drinks. At this stage, total oral intake is often insufficient to maintain weight, and supplementary PEG feeding is likely to be needed or already in place.

PEG Tube: When to Decide

The decision to place a percutaneous endoscopic gastrostomy (PEG) tube is one of the most significant clinical decisions in ALS management. It is irreversible in the sense that the procedure has permanent effects and involves procedural risk — it is not a decision to be made reactively.

The FVC threshold

The internationally accepted criterion for PEG timing is placement before forced vital capacity (FVC) drops below 50% of predicted. This threshold exists because PEG placement requires conscious sedation and puts additional demands on respiratory function that become increasingly dangerous as respiratory muscle weakness progresses.

In practice, initiating the planning conversation when FVC is at 60–65% is wiser — to allow time for investigation, multidisciplinary discussion, and scheduling without urgency. Waiting until FVC is at 50% risks arriving at 45% by the time the procedure is scheduled.

For patients whose FVC is already below 50%: A radiologically inserted gastrostomy (RIG) or percutaneous radiological gastrostomy (PRG) may be safer alternatives that do not require endoscopic sedation. Availability in HK public hospitals varies; discuss with the neurology team.

What PEG is and is not

Sialorrhoea: Managing Pooled Saliva

Sialorrhoea (drooling and pooled saliva) develops in ALS as voluntary swallowing of saliva decreases with bulbar progression. Pooled saliva is aspirated continuously and contributes significantly to aspiration pneumonia risk. Management options include:

Palliative Care Integration in Hong Kong

Early referral to palliative care — from the point of diagnosis, not only in the terminal phase — is now consensus-recommended in ALS management (NICE NG42, 2016; EFNS guidelines). Palliative care in this context means symptom management, psychosocial support, and advance care planning — not end-of-life care exclusively.

In Hong Kong, palliative care services are available through:

Advance directives

Hong Kong law permits adults with capacity to make advance directives (AD) declining specific medical treatments. For ALS patients, relevant decisions include:

These discussions are most meaningful when initiated early, while the patient has full communicative and decisional capacity. Once ALS progresses to severely impaired speech and limb function, the logistical burden of making and recording these decisions increases enormously.

For the full clinical trajectory of dysphagia in ALS, see Dysphagia in ALS/MND: Progressive Management from Early to Late Stage. For advance care planning tools in Hong Kong, see Advance Care Planning for Dysphagia Patients in HK.